Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Prevalence of antibodies to SARS-CoV-2 in healthy blood donors in New York

View ORCID ProfileKathy Kamath, View ORCID ProfileElisabeth Baum-Jones, Gregory Jordan, View ORCID ProfileWinston Haynes, View ORCID ProfileRebecca Waitz, View ORCID ProfileJohn Shon, View ORCID ProfileSteve Kujawa, Lyn Fitzgibbons, View ORCID ProfileDebra Kessler, View ORCID ProfileLarry Luchsinger, Yale IMPACT Team, Patrick Daugherty
doi: https://doi.org/10.1101/2020.10.19.20215368
Kathy Kamath
1Serimmune, Inc., 150 Castilian Dr, Suite 100, Goleta, CA 93117 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kathy Kamath
  • For correspondence: kathy@serimmune.com
Elisabeth Baum-Jones
1Serimmune, Inc., 150 Castilian Dr, Suite 100, Goleta, CA 93117 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Elisabeth Baum-Jones
Gregory Jordan
1Serimmune, Inc., 150 Castilian Dr, Suite 100, Goleta, CA 93117 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Winston Haynes
1Serimmune, Inc., 150 Castilian Dr, Suite 100, Goleta, CA 93117 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Winston Haynes
Rebecca Waitz
1Serimmune, Inc., 150 Castilian Dr, Suite 100, Goleta, CA 93117 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Rebecca Waitz
John Shon
1Serimmune, Inc., 150 Castilian Dr, Suite 100, Goleta, CA 93117 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for John Shon
Steve Kujawa
1Serimmune, Inc., 150 Castilian Dr, Suite 100, Goleta, CA 93117 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Steve Kujawa
Lyn Fitzgibbons
2Santa Barbara Cottage Hospital, 2400 Bath St., Santa Barbara, CA 93105 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Debra Kessler
3th, New York, NY 10065 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Debra Kessler
Larry Luchsinger
3th, New York, NY 10065 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Larry Luchsinger
4Yale University School of Medicine 60 College St., New Haven, CT 06510 USA
Patrick Daugherty
1Serimmune, Inc., 150 Castilian Dr, Suite 100, Goleta, CA 93117 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Despite the high level of morbidity and mortality worldwide, there is increasing evidence for asymptomatic carriers of the novel coronavirus SARS-CoV-2. We analyzed blood specimens from 1,559 healthy blood donors, collected in the greater New York metropolitan area between the months of March and July 2020 for antibodies to SARS-CoV-2 virus. Using our proprietary technology, SERA (Serum Epitope Repertoire Analysis), we observed a significant increase in SARS-CoV-2 seropositivity rates over the four-month period, from 0% [95% CI: 0 - 1.5%] (March) to 11.6% [6.0 - 21.2%] (July). Follow-up ELISA tests using S1 and nucleocapsid viral proteins confirmed most of these results. Our findings are consistent with seroprevalence studies within the region and with reports that SARS-COV-2 infections can be asymptomatic or cause only mild symptoms.

IMPORTANCE The COVID-19 pandemic, caused by the novel coronavirus SARS-CoV-2, has caused vast morbidity and mortality worldwide, yet several studies indicate that there may be a significant number of infected people who are asymptomatic or exhibit mild symptoms. In this study, samples were collected from healthy blood donors in a region of rapidly increasing disease burden (New York metropolitan area) and we hypothesized that a subset would be seropositive to SARS-CoV-2. People who experienced mild or no symptoms during SARS-CoV-2 infection may represent a source for convalescent plasma donors.

Competing Interest Statement

Serimmune employees (K.K., E.B.J., G.J., W.H., R.W., J.S., S.K., P.D.) receive salary and stock options from Serimmune.

Funding Statement

SARS-CoV-2 sample collection and curation by the Yale IMPACT team was supported by the Yale COVID-19 resource research fund.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Santa Barbara Cottage Hospital IRB and Yale IMPACT COVID-19 resource research IRB

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Members of the Yale IMPACT Team Kelly Anastasio, Michael H. Askenase, Maria Batsu, Santos Bermejo, Kristina Brower, Molly L. Bucklin, Staci Cahill, Melissa Campbell, Yiyun Cao, Arnau Casanovas-Massana, Rupak Datta, Giuseppe DeIuliis, Charles Dela Cruz, Rebecca Earnest, Shelli Farhadian, John Fournier, Bertie Geng, Nathan Grubaugh, Ryan Handoko, Akiko Iwasaki, William Khoury-Hanold, Lynda Knaggs, Albert Ko, Maxine Kuang, Sarah Lapidus, Anjelica Martin, Irene Matos, David McDonald, Maksym Minasyan, Adam J. Moore, M. Catherine Muenker, Nida Naushad, Allison Nelson, Jessica Nouws, Angela Nunez, Hong-Jai Park, Xiaohua Peng, Tyler Rice, Kadi-Ann Rose, Lorenzo Sewanan, Lokesh Sharma, Denise Shepard, Mikhail Smolgovsky, Nicole Sonnert, Yvette Strong, Codruta Todeasa, Jordan Valdez, Sofia Velazquez, Pavithra Vijayakumar, Elizabeth B. White, Anne L. Wyllie

Data Availability

Data from SERA assay is not available.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted October 21, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Prevalence of antibodies to SARS-CoV-2 in healthy blood donors in New York
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Prevalence of antibodies to SARS-CoV-2 in healthy blood donors in New York
Kathy Kamath, Elisabeth Baum-Jones, Gregory Jordan, Winston Haynes, Rebecca Waitz, John Shon, Steve Kujawa, Lyn Fitzgibbons, Debra Kessler, Larry Luchsinger, Yale IMPACT Team, Patrick Daugherty
medRxiv 2020.10.19.20215368; doi: https://doi.org/10.1101/2020.10.19.20215368
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Prevalence of antibodies to SARS-CoV-2 in healthy blood donors in New York
Kathy Kamath, Elisabeth Baum-Jones, Gregory Jordan, Winston Haynes, Rebecca Waitz, John Shon, Steve Kujawa, Lyn Fitzgibbons, Debra Kessler, Larry Luchsinger, Yale IMPACT Team, Patrick Daugherty
medRxiv 2020.10.19.20215368; doi: https://doi.org/10.1101/2020.10.19.20215368

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (269)
  • Allergy and Immunology (549)
  • Anesthesia (134)
  • Cardiovascular Medicine (1747)
  • Dentistry and Oral Medicine (238)
  • Dermatology (172)
  • Emergency Medicine (310)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (653)
  • Epidemiology (10780)
  • Forensic Medicine (8)
  • Gastroenterology (584)
  • Genetic and Genomic Medicine (2933)
  • Geriatric Medicine (286)
  • Health Economics (531)
  • Health Informatics (1918)
  • Health Policy (833)
  • Health Systems and Quality Improvement (743)
  • Hematology (290)
  • HIV/AIDS (627)
  • Infectious Diseases (except HIV/AIDS) (12496)
  • Intensive Care and Critical Care Medicine (684)
  • Medical Education (299)
  • Medical Ethics (86)
  • Nephrology (321)
  • Neurology (2780)
  • Nursing (150)
  • Nutrition (431)
  • Obstetrics and Gynecology (554)
  • Occupational and Environmental Health (597)
  • Oncology (1454)
  • Ophthalmology (440)
  • Orthopedics (172)
  • Otolaryngology (255)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (379)
  • Pediatrics (865)
  • Pharmacology and Therapeutics (362)
  • Primary Care Research (333)
  • Psychiatry and Clinical Psychology (2630)
  • Public and Global Health (5338)
  • Radiology and Imaging (1002)
  • Rehabilitation Medicine and Physical Therapy (594)
  • Respiratory Medicine (722)
  • Rheumatology (329)
  • Sexual and Reproductive Health (288)
  • Sports Medicine (278)
  • Surgery (327)
  • Toxicology (47)
  • Transplantation (149)
  • Urology (125)